NCT05694286

A Prospective Evaluation of Infraorbital Filler Injection

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: Female
• Age: 22 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.

Detailed description

Undereye or infraorbital hollowing is a result of a loss of volume causing shadowing and darkness of the infraorbital region often interpreted as a tired, stressed, and aged appearance. The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography and to complete a validated patient satisfaction questionnaire at 2 weeks, 1 month, and 3 months post-injection. 3D photogrammetry technology allows for high level feature enhancement and microscopic anatomical evaluation that was not previously possible and can be used to make volumetric measurements at injection sites to evaluating minimally invasive injection efficacy.

Conditions

• Dermal Filler
• Rejuvenation

Interventions

Type	Name	Description
PROCEDURE	Juvederm Volbella XC hyaluronic acid dermal filler injection	Infraorbital filler injection

Timeline

• Start date: 2023-01-06
• Primary completion: 2023-04-29
• Completion: 2023-06-29
• First posted: 2023-01-23
• Last updated: 2025-01-08
• Results posted: 2025-01-08

Locations

1 site across 1 country: United States